185 related articles for article (PubMed ID: 33833145)
1. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
[TBL] [Abstract][Full Text] [Related]
3. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
4. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
[TBL] [Abstract][Full Text] [Related]
6. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
7. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
8. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
9. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
11. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
[TBL] [Abstract][Full Text] [Related]
12. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
[TBL] [Abstract][Full Text] [Related]
13. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
14. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
[TBL] [Abstract][Full Text] [Related]
15. Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Kawai K; Shiratori H; Hata K; Nozawa H; Tanaka T; Nishikawa T; Murono K; Ishihara S
Dis Colon Rectum; 2021 Mar; 64(3):274-283. PubMed ID: 33395141
[TBL] [Abstract][Full Text] [Related]
16. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
[TBL] [Abstract][Full Text] [Related]
18. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
19. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
